Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
Date:11/9/2011

at could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the timing of regulatory review and approval is uncertain; regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than we or others do, request additional information, have additional recommendations or change their guidance or requirements before or after approval; the risk that data and other information related to Arena's research and development programs may not meet safety or efficacy requirements or otherwise be sufficient for regulatory approval; Arena's response to the CRL for the lorcaserin NDA or submission of a Marketing Authorization Application for regulatory approval of lorcaserin may not be submitted when anticipated, if at all; unexpected or unfavorable new data; risks related to commercializing new products; Arena's ability to obtain and defend its patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; Arena's ability to obtain adequate funds; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; and satisfactory resolution of pending and any future litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Arena
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
2. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
3. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
4. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
5. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
6. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
7. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
8. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
9. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... , October 17, 2014 ... report "Optical Imaging Market by Technique (Optical Coherence ... Imaging software) & by Application (Ophthalmology, Neurology, Oncology, Cardiology) ... MarketsandMarkets, this report studies the Optical Imaging market ... market was valued at $917.1 million in ...
(Date:10/17/2014)... BALTIMORE, Md. , Oct. 17, 2014 /PRNewswire-USNewswire/ ... Center for Medical Technology Policy: The ... from the FDA, public and private payers, medical ... representatives, clinicians, and other experts January 12, 2015 ... effectiveness and value of weight loss treatments.  Participants ...
(Date:10/17/2014)... Oct. 17, 2014  Ameritox SM , the nation,s ... of Thomas Smith , M.D., as Chief Medical ... team offering scientific resources for healthcare providers, patients and ... leadership positions at a variety of healthcare companies that ... the pain and behavioral health sides of Ameritox,s business. ...
Breaking Medicine Technology:Optical Imaging Market Worth $1,669.2 Million by 2019 2Optical Imaging Market Worth $1,669.2 Million by 2019 3Optical Imaging Market Worth $1,669.2 Million by 2019 4Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2Ameritox Appoints New Chief Medical Officer 2
(Date:10/20/2014)... Final Cut Pro X Plugin developers from Pixel ... for FCPX filmmakers . , “Fun, cool, and simple ... theme” Says Christina Austin, CEO of Pixel Film Studios. “It ... Citrus comes with all the tools needed for a ... for added style, a title screen for an introduction, two ...
(Date:10/20/2014)... Houston, Texas (PRWEB) October 20, 2014 ... invited to present the key elements of his innovative ... visiting professor to plastic surgery residents and faculty at ... (UTMB) , where he, too, was once a medical ... of the largest private cosmetic plastic surgery practices in ...
(Date:10/19/2014)... 2014 Recently, BambooIndustry.com, one of the ... new range of bamboo deckings . Moreover, the ... items; they are now available at deeply discounted rates. ... is hard to overstate the significance of online business ... online services. The company’s workers are striving to deliver ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest ... and HostMonster are the best VPS hosting suppliers ... is the method of partitioning a physical server ... the appearance and capabilities of running on someone’s ... pays close attention to VPS products and related ...
(Date:10/19/2014)... 2014 Stephen T. Greenberg, M.D., with offices ... the 10th consecutive year as one of Long Island’s best ... also been nominated as the best provider for Botox injections. ... best Day Spa and best Laser Treatment center on Long ... readers can vote for the contest once per day, per ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2
... , As one of 10 physician groups in national ... care for third year , , ANN ARBOR, ... or who require cancer screenings, are getting better treatment than ever ... costing less, according to a new report. , , ...
... , , SCHAUMBURG, Ill., Aug. 18 ... business of Motor o la, Inc. (NYSE: ... AirDefense Wireless Vulnerability Assessment solution , a patented wireless security technology ... provides a completely new method to secure wi r ...
... , , , ... DRRX ) today announced that it has signed ... a diversified multinational pharmaceutical, healthcare and consumer products company with ... Pharma development and commercialization rights in selected Asian and South ...
... , , SAN ... to college campuses this month, The American Council on Exercise (ACE), ... certification, education and training organizations in the world, today revealed its ... for the 2009 school year. A study published this year ...
... PALO ALTO, Calif., Aug. 18 Nfocus Neuromedical Inc. ... novel guiding catheter, the Echo(TM) Distal Access Guiding Catheter, ... " Nfocus works closely with key clinical opinion leaders to ... Echo is our latest success story," said President and CEO ...
... , , , ... DUBLIN, Ohio, Aug. 18 Cardinal Health today reported fiscal 2009 diluted ... a non-GAAP basis(1), which was in line with the company,s expectations and ... Martindale injectable manufacturing business as discontinued operations. , , ...
Cached Medicine News:Health News:U-M Improved Preventive and Chronic Care and Saved Medicare $$ 2Health News:U-M Improved Preventive and Chronic Care and Saved Medicare $$ 3Health News:U-M Improved Preventive and Chronic Care and Saved Medicare $$ 4Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 2Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 3Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 4Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 5Health News:DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 2Health News:DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 3Health News:DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 4Health News:American Council on Exercise (ACE) Announces Top Ten Tips to Avoid the 'Freshman 15' 2Health News:American Council on Exercise (ACE) Announces Top Ten Tips to Avoid the 'Freshman 15' 3Health News:Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni-body Internal Skeleton 2Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 2Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 3Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 4Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 5Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 6Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 7Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 8Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 9Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 10Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 11Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 12Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 13Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 14Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 15Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 16Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 17Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 18Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 19Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 20Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 21Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 22Health News:Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook 23
... The CA-1000 counts a Petri dish ... on the optical characteristics of the colonies ... The CA-1000 is equipped with three types ... are lighter or darker than the agar ...
Basic critical care testing. Measures pH, pCO2, and pO2 from 85 L whole-blood sample....
... Rapidpoint 400 is a sophisticated whole blood ... point-of-care testing while also satisfying the stringent ... multiple-use measurement cartridge contains all of the ... long-lasting cartridge includes the sampling unit, all ...
The AVL Omni modular system is a complete blood gas solution designed for high-volume critical care use, with customized test combinations, minimum intervention and flexibility....
Medicine Products: